Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Science. 2018 Feb 23;359(6378):920-926. doi: 10.1126/science.aao2774.
Science. 2018.
PMID: 29472484
Free PMC article.
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial.
Anandappa G, Lampis A, Cunningham D, Khan KH, Kouvelakis K, Vlachogiannis G, Hedayat S, Tunariu N, Rao S, Watkins D, Starling N, Braconi C, Darvish-Damavandi M, Lote H, Thomas J, Peckitt C, Kalaitzaki R, Khan N, Fotiadis N, Rugge M, Begum R, Rana I, Bryant A, Hahne JC, Chau I, Fassan M, Valeri N.
Anandappa G, et al. Among authors: darvish damavandi m.
Clin Cancer Res. 2019 Jul 1;25(13):3830-3838. doi: 10.1158/1078-0432.CCR-18-3769. Epub 2019 Apr 5.
Clin Cancer Res. 2019.
PMID: 30952636
Clinical Trial.
Item in Clipboard
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.
Brevini T, Maes M, Webb GJ, John BV, Fuchs CD, Buescher G, Wang L, Griffiths C, Brown ML, Scott WE 3rd, Pereyra-Gerber P, Gelson WTH, Brown S, Dillon S, Muraro D, Sharp J, Neary M, Box H, Tatham L, Stewart J, Curley P, Pertinez H, Forrest S, Mlcochova P, Varankar SS, Darvish-Damavandi M, Mulcahy VL, Kuc RE, Williams TL, Heslop JA, Rossetti D, Tysoe OC, Galanakis V, Vila-Gonzalez M, Crozier TWM, Bargehr J, Sinha S, Upponi SS, Fear C, Swift L, Saeb-Parsy K, Davies SE, Wester A, Hagström H, Melum E, Clements D, Humphreys P, Herriott J, Kijak E, Cox H, Bramwell C, Valentijn A, Illingworth CJR; UK-PBC Consortium; Dahman B, Bastaich DR, Ferreira RD, Marjot T, Barnes E, Moon AM, Barritt AS 4th, Gupta RK, Baker S, Davenport AP, Corbett G, Gorgoulis VG, Buczacki SJA, Lee JH, Matheson NJ, Trauner M, Fisher AJ, Gibbs P, Butler AJ, Watson CJE, Mells GF, Dougan G, Owen A, Lohse AW, Vallier L, Sampaziotis F.
Brevini T, et al. Among authors: darvish damavandi m.
Nature. 2023 Mar;615(7950):134-142. doi: 10.1038/s41586-022-05594-0. Epub 2022 Dec 5.
Nature. 2023.
PMID: 36470304
Free PMC article.
Item in Clipboard
Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer.
Clifford RE, Govindarajah N, Bowden D, Sutton P, Glenn M, Darvish-Damavandi M, Buczacki S, McDermott U, Szulc Z, Ogretmen B, Parsons JL, Vimalachandran D.
Clifford RE, et al. Among authors: darvish damavandi m.
Cells. 2020 Dec 15;9(12):2693. doi: 10.3390/cells9122693.
Cells. 2020.
PMID: 33334013
Free PMC article.
Item in Clipboard
An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
Darvish-Damavandi M, Laycock J, Ward C, van Driel MS, Goldgraben MA, Buczacki SJ.
Darvish-Damavandi M, et al.
Br J Surg. 2020 Oct;107(11):e452-e454. doi: 10.1002/bjs.11911. Epub 2020 Aug 10.
Br J Surg. 2020.
PMID: 32776522
Free PMC article.
No abstract available.
Item in Clipboard
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
Beach C, MacLean D, Majorova D, Melemenidis S, Nambiar DK, Kim RK, Valbuena GN, Guglietta S, Krieg C, Darvish-Damavandi M, Suwa T, Easton A, Hillson LV, McCulloch AK, McMahon RK, Pennel K, Edwards J, O'Cathail SM, Roxburgh CS, Domingo E, Moon EJ, Jiang D, Jiang Y, Zhang Q, Koong AC, Woodruff TM, Graves EE, Maughan T, Buczacki SJ, Stucki M, Le QT, Leedham SJ, Giaccia AJ, Olcina MM.
Beach C, et al. Among authors: darvish damavandi m.
J Clin Invest. 2023 Dec 1;133(23):e168277. doi: 10.1172/JCI168277.
J Clin Invest. 2023.
PMID: 37824211
Free PMC article.
Item in Clipboard
Towards the development of an enzyme replacement therapy for the metabolic disorder propionic acidemia.
Darvish-Damavandi M, Ho HK, Kang TS.
Darvish-Damavandi M, et al.
Mol Genet Metab Rep. 2016 Jul 27;8:51-60. doi: 10.1016/j.ymgmr.2016.06.009. eCollection 2016 Sep.
Mol Genet Metab Rep. 2016.
PMID: 27504265
Free PMC article.
Item in Clipboard
A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.
Darvish-Damavandi M, Nikfar S, Abdollahi M.
Darvish-Damavandi M, et al.
World J Gastroenterol. 2010 Feb 7;16(5):547-53. doi: 10.3748/wjg.v16.i5.547.
World J Gastroenterol. 2010.
PMID: 20128021
Free PMC article.
Review.
Item in Clipboard
Cite
Cite